Transplantation
Transplantation in military medicine covers solid organs, vascularized composite allografts, tissue grafts and vascular conduits. It requires graft preservation, ischemia–reperfusion mitigation, infection control, and targeted immunomodulation to achieve durable function in polytrauma and delayed-evacuation environments.
Technical Challenges
Immune rejection and the need for rapid, durable immunomodulation with minimized systemic toxicity.
Limited organ and tissue preservation time; ischemia–reperfusion injury that degrades graft function.
Infection risk and antimicrobial resistance (biofilms on implants, contaminated wounds) that jeopardize graft survival.
Logistics of donor matching, cold-chain/portable preservation, and surgical capability in austere or prolonged-field-care settings.
Complexity of vascularized composite allotransplantation (VCA) including nerve integration and functional rehabilitation.
Emerging Opportunities
Portable, extended-duration perfusion and biopreservation systems to maintain graft viability during delayed evacuation.
Targeted, short-course immunomodulatory regimens or tolerance-induction strategies suitable for combat casualties.
Rapid point-of-care diagnostics to assess graft viability, infection, and immune activation in forward environments.
Antimicrobial, anti-biofilm surfaces and infection-resistant graft materials compatible with tissue regeneration.
Scalable manufacturing and GMP pathways for engineered tissues and cell-based grafts deployable to DoD partners.
Current and Emerging Technologies in Transplantation
Ex vivo organ and tissue perfusion
Normothermic and hypothermic perfusion platforms extend preservation windows, enable metabolic support, and permit therapeutic delivery to reverse ischemia–reperfusion injury prior to implantation.
Immunomodulation and tolerance induction
Targeted biologics, cell therapies (e.g., regulatory T cells), costimulation blockade, and localized immunosuppression aim to prevent rejection while preserving host defenses against infection.
Tissue engineering and 3D bioprinting
Scaffold-based grafts, cell-seeded matrices, and bioprinted tissues target reconstruction of bone, nerve, skin, and composite structures for functional restoration after blast and degloving injuries.
Vascularized composite allotransplantation (VCA) & nerve regeneration
Advances in microsurgery, axonal guidance, and interface technologies improve motor and sensory integration for limbs and facial grafts critical to return-to-duty and quality-of-life outcomes.
Point-of-care viability diagnostics and biosensors
Microfluidic assays, metabolomic markers, and portable imaging assess perfusion, oxygenation, and infection risk to inform surgical decisions in forward-deployed settings.
Antimicrobial coatings and anti-biofilm strategies
Surface modifications, release kinetics, and novel antimicrobials reduce implant-associated infections and improve graft take in contaminated combat wounds.
Importance to Military Medicine
Combat casualty care & polytrauma
Transplantation and tissue replacement restore vital structures lost to blast, ballistic, and crush injuries, directly impacting survival and long-term function.
Prolonged and delayed evacuation care
Portable preservation and in-field diagnostics enable safe transport and timing for transplantation when evacuation is delayed or resources are limited.
Austere reconstruction and function restoration
VCA and engineered tissues can return complex function—speech, limb use, facial expression—critical for reintegration and readiness.
Force readiness and long-term recovery
Reducing disability and accelerating rehabilitation preserves military capability and reduces lifetime medical burden for veterans and families.
Alignment with the MTEC Mission
Transplantation aligns with MTEC’s mission to accelerate military-relevant biomedical technologies from concept to clinic through DoD-focused consortia and translational funding.
Multidisciplinary approaches—surgery, bioengineering, infectious disease, and logistics—match MTEC’s portfolio model and enable dual-use impact for civilians.
MTEC channels rapid evaluation, clinical trial design, and GMP partnerships essential for bringing advanced preservation, engineered grafts, and immunotherapies to operational use.
Dual-Use (Military + Civilian) Applications
Trauma centers and forward surgical teams benefit from portable perfusion and rapid viability assays that translate directly to civilian transplant and emergency medicine.
Disaster response and mass-casualty settings leverage scalable tissue-engineering solutions and logistics innovations developed for military deployment.
Chronic organ failure care and reconstructive surgery in civilian healthcare gain from DoD-driven improvements in preservation, infection control, and immunotherapy safety.
Regenerative technologies for nerve and soft-tissue repair developed for battlefield injuries have broad civilian application in orthopedics and reconstructive microsurgery.
Explore MTEC Members with Transplantation Capabilities
MTEC members bring translational expertise—clinical trial execution, DoD clinical site access, and regulatory strategy—accelerating surgical and biologic transplantation solutions to deployment.
Industry partners provide scalable manufacturing and GMP production for engineered tissues and cell therapies, while academic teams innovate preservation and immunologic approaches.
Clinical and military end-users validate technologies in relevant environments, ensuring solutions meet operational constraints such as portability, durability, and rapid decision-making.
Explore member profiles to identify collaborators with surgical, biofabrication, preservation, infectious disease, and regulatory capabilities ready to advance transplantation innovations for Warfighters and civilians.
50 Members with Transplantation capabilities.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.
VirTech Bio is an early-stage biotechnology company based in Natick, Massachusetts, focused on developing a human-derived hemoglobin-based oxygen carrier (HBOC) for use as a temporary blood substitute in trauma and transplantation. The company leverages expertise in hemoglobin polymerization to address critical needs in emergency medicine and organ preservation, with a pipeline also targeting veterinary and research applications. Process innovations allow scalable and contract-based manufacturing, supported by significant non-dilutive funding from the US Department of Defense and private investment.
Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.
Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.
Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.
Profusa, Inc. is a pioneering digital health company based in the San Francisco Bay Area, dedicated to making the body’s chemistry easily accessible to improve health and wellness. Profusa develops tissue-integrating biosensors for continuous, real-time monitoring of body chemistries, empowering individuals and clinicians with actionable, medical-grade data to transform personal health management and disease prevention. Their unique bioengineering approach overcomes the foreign body response, enabling long-term, in-body monitoring through tiny, flexible biosensors that become one with the body. Profusa’s technology platform supports both consumer and medical applications, with a vision to revolutionize personalized medicine and digital health. The company is supported by significant grant funding from agencies such as DARPA and NIH, and collaborates with leading academic, hospital, and industry partners worldwide.
Blood Centers of America (BCA) is the largest blood supply network in the United States, comprising over 60 independent community blood centers that collectively distribute approximately 50% of the nation's blood supply. BCA supports member organizations through supply chain solutions, donor recruitment, advocacy, disaster response, and purchasing power. In addition to providing whole blood, red blood cells, platelets, plasma, cells, and tissues for therapeutic, diagnostic, research, and advanced therapy applications, BCA and its network are engaged in the development and delivery of advanced therapies including cell and gene therapy starting materials, processing, and manufacturing. BCA actively mobilizes resources in response to national emergencies, pandemics, and technological advances in donor experience and biotherapeutics.
RION is a clinical-stage regenerative medicine company based in Rochester, MN, focused on revolutionizing exosome science to heal from within. Established in 2017, RION leverages the unique properties of exosomes derived from platelets to develop innovative therapies aimed at enhancing tissue regeneration and addressing various medical challenges.
The University of North Carolina Wilmington (UNCW) is a top doctoral and research institution located in Wilmington, North Carolina. Established in 1947, UNCW has grown to serve nearly 18,000 students and employs about 2,500 staff. The university is dedicated to providing a powerful academic experience that fosters creative inquiry, critical thinking, and thoughtful expression in a beautiful coastal setting. UNCW is committed to educational excellence, community engagement, and global connections, making it a vibrant part of the southeastern North Carolina community. UNCW also emphasizes the importance of freedom of expression and mutual respect within its diverse community.
CellBios is a biotechnology company specializing in the design, development, and manufacturing of single-use bioprocessing and medical device solutions for healthcare, biotechnology, and regenerative medicine sectors. The company operates GMP and ISO-certified cleanroom facilities, offering a comprehensive portfolio of cryopreservation products, bioreactors, fluid management systems, advanced packaging, and specialty devices. By leveraging expertise in extrusion, molding, assembly, sterilization, quality control, and regulatory compliance, CellBios provides customized, scalable solutions to support blood transfusion, cell and gene therapy, biologics manufacturing, and clinical workflows.
The University of Missouri-Kansas City (UMKC) is dedicated to transforming today's learners into tomorrow's leaders through innovative education, research, and community engagement. With over 125 academic programs, UMKC fosters a diverse and inclusive environment that empowers students to achieve their goals and make a positive impact in their communities.
Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world, dedicated to providing high-quality, patient-centered care. With a history of innovation spanning nearly 150 years, Mayo Clinic is committed to transforming healthcare through research, education, and compassionate care, ensuring that the best possible treatment is available to everyone.
The Office of Sponsored Projects Administration (OSPA) at the University of Kentucky is dedicated to transforming tomorrow by streamlining grants and contracts. OSPA provides essential services to faculty and staff, including assistance with proposal preparation, award negotiation, and compliance with sponsor policies.
Southwest Research Institute (SwRI) is a nonprofit research and development organization that provides independent, premier services to government and industry clients. Founded in 1947, SwRI is committed to advancing science and technology to benefit humanity, focusing on innovative solutions that improve human health and safety. With a diverse range of technical divisions, SwRI addresses complex challenges in various fields including mechanical engineering, materials, aerospace, automotive, biomedical, and more.
The University of Texas at Dallas (UT Dallas) is a top public research university located in Richardson, Texas, known for its innovative programs, renowned faculty, and a commitment to academic excellence. With over 31,000 students across seven schools, UT Dallas offers a diverse range of undergraduate and graduate programs designed to prepare students for leadership roles in various fields including science, engineering, business, and the arts. The university emphasizes research, community engagement, and student success, making it a vibrant hub for learning and innovation. Additionally, UT Dallas is recognized for its strong return on investment, high graduation rates, and successful career placement for graduates, with many students continuing their education at prestigious graduate schools.

Moberg Analytics
Moberg Analytics – Advanced Brain Monitoring & Critical Care Informatic
Moberg’s platform unifies brain monitoring data for faster, precise treatment of severe brain injuries in military and civilian care.
University of California San Francisco
TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness
TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.
Arizona State University
ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience
Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.
University of Pittsburgh
Topical Metformin Lotion for Tendinopathy Prevention
University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.